MYMeina Ye

Meina Ye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meina Ye has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Hongfeng Chen

    Department of Traditional Chinese Medicine Breast Surgery,Shanghai,CHINA. LongHua Hospital,Shanghai,CHINA. Shanghai University of Traditional Chinese Medicine,Shanghai,CHINA

    3 shared publications
  • Yulian Yin

    Department of Traditional Chinese Medicine Breast Surgery,Shanghai,CHINA. LongHua Hospital,Shanghai,CHINA. Shanghai University of Traditional Chinese Medicine,Shanghai,CHINA

    3 shared publications
  • Bing Wang

    Department of Traditional Chinese Medicine Breast Surgery,Shanghai,CHINA. LongHua Hospital,Shanghai,CHINA. Shanghai University of Traditional Chinese Medicine,Shanghai,CHINA

    2 shared publications
  • Jiachen Xu

    2 shared publications
  • Jingjing Wu

    Department of Traditional Chinese Medicine Breast Surgery,Shanghai,CHINA. LongHua Hospital,Shanghai,CHINA. Shanghai University of Traditional Chinese Medicine,Shanghai,CHINA

    2 shared publications
  • Siyuan Tu

    2 shared publications

Latest Publications

  • Open Access

    Repair of Areolar Defect Following the Excision of Sebaceous Cyst by Applying Kite-Flap: A Case Report and Literature Review

    by Nanyuan Jiang, Jiachen Xu, Wanling Xie, Yifei Hua, Meina Ye

    We report a case of a 68-year-old female with a 6-year history of a left medial areolar sebaceous cyst, which progressed to 12.5×16.2×8 mm and resulted in a 2.0×1.5 cm defect after complete excision. A modified kite flap with an optimized length-to-width ratio (1:1.5) and Y-suturing technique was used for repair. The operation lasted 25 minutes with 1 mL blood loss. Postoperatively, the flap achieved primary healing without complications, and bilateral breast symmetry was preserved (<3 mm diameter difference). At 6-month follow-up, the patient reported 100% satisfaction. This modified technique addresses the core challenges of small areolar defect repair, offering high tissue compatibility, minimal invasiveness, and concealed scarring.

  • Open Access

    From Non-Mass Stage to Complex Type: Ultrasonographic Assessment of Granulomatous Lobular Mastitis Across Six Clinical Stages

    by Yulian Yin, Yifan Cheng, Liangmei Zhou, Yuanyuan Zhong, Bing Wang, Jingjing Wu, Yajuan Ren, Dongwen Gao, Hongfeng Chen, Meina Ye, et al.

    Objective This study aims to summarize and validate the ultrasonographic features of granulomatous lobular mastitis (GLM) across its various clinical stages. Methods We have summarized and defined a set of disease-specific ultrasonographic features, including five subtypes of the “track sign,” as well as the “donut sign,” “false burr sign,” abscess formation, ulceration, and fistulous tracts. According to disease progression, GLM was categorized into six stages: Non-Mass Stage, Mass Stage, Abscess Stage, Late Ulceration Stage, Fistula Stage, and Complex Type (the simultaneous presence of ultrasonographic features corresponding to ≥ 2 different GLM stages within the same breast). In this study, a cohort of 273 patients was enrolled to evaluate GLM diagnosis and staging from both clinical and ultrasonographic perspectives. The diagnostic accuracy of ultrasonography was assessed, and the ultrasonographic manifestations of GLM were comprehensively delineated across its various clinical stages—with particular emphasis on the diagnostically challenging Non-Mass Stage. Results Ultrasound-based diagnosis of GLM achieved a sensitivity of 98.85%, specificity of 83.33%, and a positive predictive value (PPV) of 99.23%. Stage-specific ultrasonographic features demonstrated statistically significant associations with clinical staging: Track signs were most frequently observed in the Non-Mass Stage (92.86%). The donut sign was prevalent in both the Non-Mass (69.05%) and Abscess (66.67%) stages. The false burr sign was highly characteristic of the Mass Stage (78.69%). The Abscess Stage exhibited large mixed echogenic areas with irregular walls and internal fluid motion (100%). Late Ulceration Stage was marked by hypoechoic areas in the areolar region communicating with dilated ducts (70.37%). Fistula Stage showed duct-like hypoechoic tracts extending to the skin with thickened walls (92.68%). Complex Type cases showed overlapping features of multiple stages. These findings validate the diagnostic utility of stage-specific ultrasonographic signs and support the clinical relevance of the proposed classification system. Conclusion GLM exhibits distinct stage-specific ultrasonographic features. When combined with a standardized examination protocol and clearly defined imaging criteria, these features can significantly enhance the early detection and accurate staging of the disease. Additionally, representative images for each stage are provided to support the standardization of ultrasonographic evaluation for GLM.

  • Open Access

    Strategic framework to advance scientific innovation in clinically dominant diseases in traditional Chinese medicine: Plasma cell mastitis

    by Siyuan Tu, Yulian Yin, Jiachen Xu, Hongfeng Chen, Xueqing Wu, Yiting Jin, Wei Zhu, Na Fu, Jiayu Sheng, Xiaofei Liu, et al.

    In accordance with the Guiding Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovation of Traditional Chinese Medicine (TCM), the China Association of Chinese Medicine (CACM) organized multidisciplinary symposia on TCM-dominant diseases with the aim of advancing research on clinically dominant diseases in TCM, supporting specialty development, cultivating clinical talent, developing strategic plans for national science, and fostering academic innovation. The 42nd Academic Salon on Clinically Dominant Diseases, which was convened in Shanghai on 24 November 2024, brought together TCM experts, Western medicine experts, and interdisciplinary researchers for in-depth discussions on the current status, strengths, and limitations of and strategies to improve the integrated diagnosis and treatment of plasma cell mastitis (PCM). While consensus had been reached on recommendations for TCM and integrated approaches, detailed research pathways remain to be developed. In this work, we systematically examine the pathogenesis of and clinical management challenges related to PCM. Building on the therapeutic strengths of TCM, we propose five prioritized research domains with corresponding scientific planning: (1) Early identification and intervention strategies for PCM; (2) The optimization of TCM syndrome differentiation systems for PCM; (3) The standardization of efficient evaluation metrics for PCM therapies; (4) Mechanistic studies on the pathogenesis of PCM and TCM therapeutic targets; (5) Prevention protocols and complication management frameworks for PCM. We further delineate recommended research directions, anticipated outcomes, value propositions, and funding priorities. The aim of this research model, which was derived from the PCM-focused academic salon series, is to advance the development of high-quality TCM practices by informing national scientific planning, innovative drug development, research priorities, and the formulation of clinical guidelines.


  • Open Access

    Diagnosis of non-puerperal mastitis based on “whole tongue” features: non-invasive biomarker mining and diagnostic model construction

    by Siyuan Tu, Yulian Yin, Lina Ma, Hongfeng Chen, Meina Ye

    Background: Non-puerperal mastitis (NPM) arises from heterogeneous factors ranging from autoimmune dysregulation to occult infections. To establish a diagnosis, biopsy is reliable but invasive. Imaging exhibits a limited specificity and may cause diagnostic delays, patient discomfort, and suboptimal management. Inspired by non-invasive tongue diagnosis in traditional Chinese medicine, this study integrated tongue-coating microbiota profiling and AI-quantified tongue image phenotyping to establish an objective, non-invasive diagnostic framework for NPM.Methods: A total of 100 NPM patients from the Breast Surgery Department of Longhua Hospital and 100 healthy volunteers were included. Their clinical characteristics, tongue images, and tongue-coating microbiota data were collected. Features of tongue images (detection, segmentation, and classification) were quantitated and extracted via deep learning. The microbiota composition was assessed using 16S rRNA gene sequencing (V3–V4 region) and bioinformatic pipelines (QIIME2, DADA2). Based on clinical, imaging, and microbial features, three machine learning models—logistic regression (LR), support vector machine (SVM), and gradient boosting decision tree (GBDT)—were trained to distinguish NPM.Results: The GBDT model achieved a superior diagnostic performance (AUROC = 0.98, accuracy = 0.95, and specificity = 0.95), outperforming the LR (AUROC = 0.98, accuracy = 0.95, and specificity = 0.90) and SVM models (AUROC = 0.87, accuracy = 0.80, and specificity = 0.75). Integration of clinical characteristics, tongue image features, and bacterial profiles (at the genus/family level) yielded the highest accuracy, whereas models using a single class of features showed a lower discriminatory ability (AUROC = 0.90–0.91). Key predictors included Campylobacter (12%), waist–hip ratio (11%), and Alloprevotella (6%).Conclusions: Integrating clinical characteristics, tongue image features, and tongue-coating microbiota profiles, the multimodal GBDT model demonstrates a high diagnostic accuracy, supporting its utility for early screening and diagnosis of NPM.


  • Open Access

    A cohort study of prolactin and non-puerperal mastitis using real world data

    by Yulian Yin, Haoxin Le, Yifan Cheng, Yuanyuan Zhong, Yiqin Cheng, Bing Wang, Jingjing Wu, Meina Ye, Hongfeng Chen

    Non-puerperal mastitis (NPM) is an umbrella term for non-specific inflammatory mastitis that occurs during the non-puerperal period and has an unclear aetiology. The current study aims to characterize NPM patients and examine the determinants associated with NPM severity. This study analyzed the NPM inpatients admitted to the Department of Breast Surgery, Longhua Hospital Affiliated with the Shanghai University of Traditional Chinese Medicine from 2016 to 2020. We explored NPM patient characteristics through demographics, physical risks, lab tests, and medical history indicators. Multivariable logistic regression was conducted to identify the relationship between the prolactin (PRL) level and NPM severity stratified by breast structure. The majority of NPM inpatients had normal breast structures and were of lower average age than those with congenital nipple deformity (p = 0.002). Significant positive risk (p < 0.001) association between PRL level and NPM severity was observed among NPM inpatients with normal breast structure in both crude and adjusted models (adjusted OR: 2.91; 95%CI:1.88-4.52), with younger age as a protective factor (OR:0.94; 95%CI:0.91-0.97) and smoking history as a risk factor (OR:2.22; 95%CI:1.22-4.05). For NPM patients with nipple deformity, increasing odds of NPM severity regarding higher PRL level was observed while the result is not statistically significant at 0.05 level. (OR: 2.17; 95%CI: 0.94-5.03). The risk of NPM severe episodes is higher among patients with higher PRL levels, of which the association is stronger for NPM patients with normal breast structure, implying different pathogenesis between NPM patients with varied breast anatomy. Disagreement of the interaction effect testification indicates an improvement window for the current study.Trial registration: ChiCTR2000035929. Registered 20 August 2020(retrospectively registered).


  • Open Access

    Surgery paradigm for locally advanced breast cancer following neoadjuvant systemic therapy

    by Ziyue Sun, Kexin Liu, Yanru Guo, Nanyuan Jiang, Meina Ye

    Locally advanced breast cancer (LABC) remains a significant clinical challenge, particularly in developing countries. While neoadjuvant systemic therapy (NST) has improved the pathological complete response (pCR) rates, particularly in HER2-positive and triple-negative breast cancer patients, surgical management post-NST continues to evolve. The feasibility of omitting surgery and the increasing consideration of breast-conserving surgery, immediate reconstruction in LABC patients are important areas of exploration. Accurate assessment of tumor response to NST through advanced imaging and minimally invasive biopsies remains pivotal, though challenges persist in reliably predicting pCR. Additionally, axillary lymph node management continues to evolve, with emerging strategies aiming to minimize the extent of surgery in patients who achieve nodal downstaging post-NST. Minimizing axillary lymph node dissection in favor of less invasive approaches is gaining attention, though further evidence is needed to establish its oncological safety. The potential for personalized treatment approaches, reducing surgical morbidity, and improving quality of life are key goals in managing LABC, while maintaining the priority of achieving favorable long-term outcomes.


  • Open Access

    ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231

    by Yuzhu Zhang, Jingjing Wu, Meina Ye, Bing Wang, Jiayu Sheng, Bailing Shi, Hongfeng Chen

    Platinum-based drugs are used extensively in neoadjuvant chemotherapy for triple-negative breast cancer (TNBC), but their use can be limited by resistance. In this study, we established cisplatin (DDP) resistant TNBC cells to investigate the potential relationship among ETS1, IKKα/NF-κB and resistance. The sensitivity was evaluated by MTT, apoptosis analysis. The intracellular DDP concentration difference was tested by inductively coupled plasma mass spectrometry (ICP-MS) method. Molecular pathological mechanism of DDP resistance was explored by microarray analysis and PPI network analysis. The ETS1, NF-κB signaling change were assessed by western blot and q-PCR in vitro and vivo. The existing binds between ETS1 and the core IKKα promoter were found by luciferase assay and chromatin immunoprecipitation technique (ChIP). MDA-MB-231/DDP (231/DDP) cell had a higher IC50 value of cisplatin, lower intracellular DDP concentration, and lower apoptosis ratio than MDA-MB-231 (231/wt) cell line treated with DDP. Increased ABC transporters were induced by the activation of NF-κB pathway in 231/DDP cells. ETS1, RPL6, RBBP8, BIRC2, PIK3A and RARS were six important genes for DDP-resistance based on PPI network and expression validation. Protein expression of ETS1 and IKKα were significantly up-regulated in 231/DDP cells. However, inhibition of ETS1 expression enhances chemo-sensitivity to DDP and reversed the activation of NF-κB pathway in 231/DDP cells and subcutaneous transplantation tumor in vivo. Moreover, there is existing binds between ETS1 and the core IKKα promoter though luciferase assay and ChIP. This study enables us to understand the functions of ETS1 in TNBC chemotherapy and suggests that ETS1 could be used as a novel marker of poor response to DDP and a potential therapeutic target for TNBC chemotherapy.